These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22635233)

  • 21. Avidity of anti-β2-glycoprotein I antibodies in patients with antiphospholipid syndrome.
    Čučnik S; Kveder T; Artenjak A; Ulcova Gallova Z; Swadzba J; Musial J; Iwaniec T; Stojanovich L; Alessandri C; Valesini G; Avčin T; Cohen Tervaert JW; Rozman B; Božič B
    Lupus; 2012 Jun; 21(7):764-5. PubMed ID: 22635226
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiphospholipid antibodies in arterial thrombosis.
    Koike T
    Ann Med; 2000 Dec; 32 Suppl 1():27-31. PubMed ID: 11209978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Valine/valine genotype at position 247 of the beta2-glycoprotein I gene in Mexican patients with primary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies.
    Prieto GA; Cabral AR; Zapata-Zuñiga M; Simón AJ; Villa AR; Alarcón-Segovia D; Cabiedes J
    Arthritis Rheum; 2003 Feb; 48(2):471-4. PubMed ID: 12571857
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-beta2-glycoprotein I: prevalence, clinical correlations, and importance of persistent positivity in patients with antiphospholipid syndrome and systemic lupus erythematosus.
    Danowski A; Kickler TS; Petri M
    J Rheumatol; 2006 Sep; 33(9):1775-9. PubMed ID: 16960938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of giant phospholipid vesicles containing cardiolipin and cholesterol with beta2-glycoprotein-I and anti-beta2-glycoprotein-I antibodies.
    Ambrozic A; Cucnik S; Tomsic N; Urbanija J; Lokar M; Babnik B; Rozman B; Iglic A; Kralj-Iglic V
    Autoimmun Rev; 2006 Nov; 6(1):10-5. PubMed ID: 17110310
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Accuracy of the first fully automated method for anti-cardiolipin and anti-beta2 glycoprotein I antibody detection for the diagnosis of antiphospholipid syndrome.
    Villalta D; Alessio MG; Tampoia M; Da Re A; Stella S; Da Re M; Tozzoli R; Bizzaro N
    Ann N Y Acad Sci; 2009 Sep; 1173():21-7. PubMed ID: 19758127
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-beta(2)-glycoprotein I autoantibody expression as a potential biomarker for strokes in patients with anti-phospholipid syndrome.
    Ali HY; Abdullah ZA
    J Immunotoxicol; 2008 Apr; 5(2):173-7. PubMed ID: 18569388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts.
    Sorice M; Longo A; Capozzi A; Garofalo T; Misasi R; Alessandri C; Conti F; Buttari B; Riganò R; Ortona E; Valesini G
    Arthritis Rheum; 2007 Aug; 56(8):2687-97. PubMed ID: 17665396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI.
    Petrovas C; Vlachoyiannopoulos PG; Kordossis T; Moutsopoulos HM
    J Autoimmun; 1999 Nov; 13(3):347-55. PubMed ID: 10550222
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-β(2)GPI/β(2)GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways.
    Xie H; Zhou H; Wang H; Chen D; Xia L; Wang T; Yan J
    Mol Immunol; 2013 Mar; 53(3):246-54. PubMed ID: 22964479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-β2-glycoprotein I antibodies.
    Willis R; Pierangeli SS
    Ann N Y Acad Sci; 2013 May; 1285():44-58. PubMed ID: 23692565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined search for anti-beta2-glycoprotein I and anticardiolipin antibodies in antiphospholipid syndrome: contribution to diagnosis.
    Sanmarco M; Roll P; Gayet S; Oksman F; Johanet C; Escande A; Cohen JH; Chevailler A; Goetz J; Humbel RL; Sibilia J
    J Lab Clin Med; 2004 Sep; 144(3):141-7. PubMed ID: 15454883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patients with atherosclerotic syndrome, negative in anti-cardiolipin assays, make IgA autoantibodies that preferentially target domain 4 of beta2-GPI.
    Iverson GM; von Mühlen CA; Staub HL; Lassen AJ; Binder W; Norman GL
    J Autoimmun; 2006 Dec; 27(4):266-71. PubMed ID: 17081732
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Antibodies to beta2-glycoprotein I in systemic lupus erythematosus: new laboratory marker of antiphospholipid syndrome].
    Reshetniak TM; Derksen RV; Alekberova ZS; Horbach D; De Groot F; Nasonov EL; Kalashnikova LA; Match ES; Nasonova VA
    Klin Med (Mosk); 1998; 76(3):36-40. PubMed ID: 9575746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant domain V of β2-glycoprotein I inhibits the formation of a 7-ketocholesteryl-9-carboxynonanoate and β2-glycoprotein I complex.
    Zhang Y; Li W; Chi Y; Wang R; Wang D; Zhang F; Liu Z; Matsuura E; Liu Q
    J Biochem; 2011 Jan; 149(1):35-42. PubMed ID: 20876187
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cross-reactivity between annexin A2 and Beta-2-glycoprotein I in animal models of antiphospholipid syndrome.
    Weiss R; Bitton A; Nahary L; Arango MT; Benhar I; Blank M; Shoenfeld Y; Chapman J
    Immunol Res; 2017 Feb; 65(1):355-362. PubMed ID: 27449504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanisms of disease: antiphospholipid antibodies-from clinical association to pathologic mechanism.
    de Laat B; Mertens K; de Groot PG
    Nat Clin Pract Rheumatol; 2008 Apr; 4(4):192-9. PubMed ID: 18285765
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Binding of high-avidity anti-beta2-glycoprotein I antibodies.
    Cucnik S; Kveder T; Rozman B; Bozic B
    Rheumatology (Oxford); 2004 Nov; 43(11):1353-6. PubMed ID: 15280573
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Post-translational oxidative modification of β2-glycoprotein I and its role in the pathophysiology of the antiphospholipid syndrome.
    Mirarabshahi P; Abdelatti M; Krilis S
    Autoimmun Rev; 2012 Sep; 11(11):779-80. PubMed ID: 22240262
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.